| CAS ID: | 49562-28-9 |
| Molecular Formula: | C20H21ClO4 |
| Molecular Weight: | 360.8 g/mol |
| Monoisotopic Mass: | 360.1128 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | ANTARA (MICRONIZED) | FENOFIBRATE | FENOGLIDE | TRIGLIDE | LIPANTIL | TRICOR | LIPIDIL | LIPANTIL MICRO 200 | LIPANTIL MICRO 267 | FENOGAL | LIPANTIL MICRO 67 | SUPRALIP 160 | LIPOFEN | FENOFIBRATE (MICRONIZED) |
| Analysis: | Drug repositioning mechanism analysis |
Trial Record 1
| ClinicalTrial ID | NCT02823366 | Disease | Liver fibrosis |
| Phase | Phase 3 | Status | Unknown |
| First Received | July 6, 2016 | Last Verified | July 7, 2016 |
| Sponsor | Xijing Hospital of Digestive Diseases | ||
Trial Record 2
| ClinicalTrial ID | NCT02823353 | Disease | Liver fibrosis |
| Phase | Phase 3 | Status | Unknown |
| First Received | July 6, 2016 | Last Verified | July 7, 2016 |
| Sponsor | Xijing Hospital of Digestive Diseases | ||
Trial Record 3
| ClinicalTrial ID | NCT01141296 | Disease | Liver fibrosis |
| Phase | Phase 2 | Status | Withdrawn |
| First Received | June 10, 2010 | Last Verified | April 2, 2014 |
| Sponsor | University of Miami | ||
Trial Record 4
| ClinicalTrial ID | NCT00575042 | Disease | Liver fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | December 17, 2007 | Last Verified | March 8, 2018 |
| Sponsor | University of Florida | ||